期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

肾移植术后免疫抑制剂的合理应用 被引量：4

Appropriate Use of Immunosuppressants after Renal Transplantation
下载PDF
导出
摘要 肾脏移植目前是治疗晚期肾功能衰竭的常规临床治疗手段,其中免疫抑制疗法是肾脏移植成败的关键因素。理想的免疫抑制治疗应达到高效、低毒、安全、方便和经济的要求。充分掌握和认识各种免疫抑制药物的作用机制及其毒副作用,力争达到免疫抑制治疗的个体化方案是肾移植术后合理应用免疫抑制药物的基本原则和目标。 Kidney transplantation has became an important method in treating advanced renal failure. Immunosuppressants play a key tool in this progess. It is important to understand the goal, mechanism, and adverse effects of immunosuppressive therapy, so as to appropriately use these drugs in post-transplantation patients on a customized basis.
作者 田野 解泽林 唐雅望 孙雯 郭宏波 张磊 林俊 马麟麟
机构地区 首都医科大学附属北京友谊医院泌尿科
出处 《中国医学科学院学报》 CAS CSCD 北大核心 2009年第3期256-258,共3页 Acta Academiae Medicinae Sinicae
关键词 肾移植术后 免疫抑制剂 合理应用 post-transplantation immunosuppressants appropriate use
分类号 R617 [医药卫生—外科学] R619 [医药卫生—外科学]
  • 相关文献

参考文献10

  • 1谭建明.移植感染学[M].2版.北京:人民卫生出版社,2008:91-109.
  • 2Opelz G, Dohler B. Cyclosporine and long-term kidney graft survival [ J]. Transplantation, 2001,72(2) :1267-1273.
  • 3中华医学会器官移植学分会、中华医学会泌尿外科学分会肾移植学组.环孢素在肾移植中的应用专家共识[M].香港:华夏科学出版社,2008:4-5.
  • 4Watson C J, Firth J, Williams PF, et al. A randomized controlled trial of late conversion from CNI-based to sirolimusbased immunosuppression following renal transplantation [J]. Am J Transplant, 2005, 5(10) : 2496-2503.
  • 5Bumbea V, Kamar N, Ribes D, et al. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus [ J ]. Nephrol Dial Transplant, 2005, 20( 11 ): 2517-2523.
  • 6Weir MR. Medical management of kidney transplantation [ M ]. Philadelphia : LIPPINCOTT WILLIAMS & WILKINS, 2005 : 127-137.
  • 7Morales JM. Immunosuppressive treatment and progression of histologic lesions in kidney allografts [ J ] . Kidney Int Suppl, 2005, 99 :S124-S130.
  • 8Webster AC, Lee VW, Chapman JR, et al. Target ofrapamyein inhibitors ( sirolimus and everolimus) for primary immunosppression of kidney transplant recipients : a systematic reviw and meta-analysis of randomized trials [ J ] . Transplantation, 2006, 81 ( 9 ) : 1234-1248.
  • 9Camoistol JM, Eris J, Oberbaue R, et al. Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation [ J ]. J Am Soc Nephrol, 2006, 17(2) :581-589.
  • 10胡小鹏,马麟麟,王勇,尹航,王玮,杨晓勇,张小东.肾移植后发生尿路上皮肿瘤的患者转换西罗莫司治疗的临床观察[J].中华器官移植杂志,2008,29(10):620-622. 被引量：9

二级参考文献12

  • 1胡小朋,马麟麟,张小东,王玮,王勇,李晓北,陈晓.肾移植术后并发尿路上皮肿瘤的临床分析[J].中华泌尿外科杂志,2006,27(7):493-495. 被引量：18
  • 2Luan FL, Ding R, Sharma VK. et al. Rapamycin is an effective inhibitor of human renal cancer metastasis . Kidney Int, 2003, 63(3) : 917-926.
  • 3Kahan BD, Knight R. Schoenherg L. et al. Ten years of sirolimus therapy for human renal transplantation: the University of Texas at Houston experience. Transplant Proc, 2003, 35 Suppl 3 : S25-34.
  • 4Campistol JM, Eris J, Oberbauer R , et al. Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation . J Am Soc Nephrol ,2006 , 17 (2) :581-589.
  • 5Kochl GE. Andrassy J. Guba M, et al . Rapamycin protects allografts from rejection while simuhaneously attacking tumors in immunosuppressed mice. Transplantation , 2004 , 77 (9) : 1319- 1326.
  • 6Abraham RT. Wiederrecht GJ. Immunopharmacology of rapamycin. Annu Rev Immunol, 1996, 14 (3) : 483-510.
  • 7Fingar DC. Blenis J, The target of rapamycin (TOR) : an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression. Oncogene, 2004, 23 (18) : 3151-3171.
  • 8Koehl G, Guba M, Sceliger H, et al. Rapamycin treatment at immunosuppressive doses affects tumor blood vessel circulation. Transplant Proc.2003,56(6) :2135- 2136.
  • 9Huang S, Shu L, Dilling MB. el al. Suslained activation of the iNK cascade and rapamycin-induced apop tosis arc supp ressed by p53 /p21 (Cip1). J Mol Cell. 2003, 11 (6) :1491- 1501.
  • 10Kahan BD. Napoli KL , Kelly PA , et al. Therapeutic drug monitoring of sirolimus : correlations with efficacy anti toxicity. Clin Transplant . 2000 . 14(2) :97-109.

共引文献8

同被引文献49

  • 1Fangmann J,Arns W,Marti HP,et al.Impact of daclizumab,low-dose cyclosporine,mycophenolate mofetil and steroids on renal function after kidney transplantation.Nephrol Dial Transplant,2010,25 (1):283-292.
  • 2Marcén R.Immunosuppressive drugs in kidney transplantation:impact on patient survival,and incidence of cardiovascular disease,malignancy and infection.Drugs,2009,69(16):2227-2243.
  • 3Taniai N,Akimaru K,Ishikawa Y,et al.Hepatotoxicity caused by both tacrolimus and cyclosporine after living donor liver transplantation,J Nippon Med Sch,2008,75 (3):187-191.
  • 4Videla C,Vega J,Borja H.Hepatotoxicity associated with cyclosporine monitoring using C2 recommendations in adults renal recipients receiving ketoconazole.Transplant Proc,2005,37 (3):1574-1576.
  • 5Kandaswamy R,Humar A,Casingal V,et al.Stable kidney function in the second decade after kidney transplantation while on cyclosporine-based immunosuppression.Transplantation,2007,83(6):722-726.
  • 6Flechner SM,Kobashigawa J,Klintmalm G.Calcineurin inhibitor-sparing regimens in solid organ transplantation:focus on improving renal function and nephrotoxicity.Clin Transplant,2008,22 (1):1-15.
  • 7Anil KumarMS,Irfan Saeed M,Ranganna K,et al.Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy:five-year outcomes.Transpl Immunol,2008,20(1-2):32-42.
  • 8Roncarolo MG, Gregori S, Battaglia M, et al. Interleukin - 10 - secreting type 1 regulatory T cells in rodents and humans[ J]. Immunol Rev,2006,212(8) : 28 -50.
  • 9RoncaroloMG, BattagliaM. Regulatory T - cell immunotherapy for tolerance to self- antigens and alloantigens in humans[ J]. Nat Rev Im- munol,2007,7(8) : 585 -598.
  • 10Sakaguchi S, Sakaguchi N, AsanoM, et al. Immunologic self-tolerance maintained by activated T cells expressing IL -2 receptor a - chains ( CD25 ). Breakdown of a single mechanism of selftolerance causes various autoimmune diseases [ J]. Immunol, 1995,155 ( 3 ) : 1151 -1164.

引证文献4

二级引证文献7

中国医学科学院学报
2009年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部